These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

321 related items for PubMed ID: 19603251

  • 1. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
    Katayama K, Matsuno T.
    Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
    Katayama K, Okubo T, Sato T, Ito H, Fukai R, Baba H.
    Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
    [Abstract] [Full Text] [Related]

  • 3. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J, Díaz-Torné C, Ruiz JM, Hernández MV, Torrente-Segarra V, Ros S, Rodriguez de la Serna A, Díaz-López C, Sanmartí R, Nolla JM.
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of leflunomide addition in relation to prognostic factors for patients with active early rheumatoid arthritis failing to methotrexate in daily practice.
    Sakellariou GT, Sayegh FE, Kapetanos GA, Berberidis C.
    Clin Rheumatol; 2012 Jan; 31(1):163-7. PubMed ID: 21904814
    [Abstract] [Full Text] [Related]

  • 5. Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
    Sharp JT, Strand V, Leung H, Hurley F, Loew-Friedrich I.
    Arthritis Rheum; 2000 Mar; 43(3):495-505. PubMed ID: 10728741
    [Abstract] [Full Text] [Related]

  • 6. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.
    Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
    [Abstract] [Full Text] [Related]

  • 7. Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study.
    Aletaha D, Stamm T, Kapral T, Eberl G, Grisar J, Machold KP, Smolen JS.
    Ann Rheum Dis; 2003 Oct; 62(10):944-51. PubMed ID: 12972472
    [Abstract] [Full Text] [Related]

  • 8. Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.
    Sakellariou GT, Sayegh FE, Anastasilakis AD, Kapetanos GA.
    Rheumatol Int; 2013 Nov; 33(11):2917-20. PubMed ID: 23124729
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of weekly leflunomide for the treatment of early rheumatoid arthritis: a randomized, multi-center study.
    Ren LM, Li R, Chen LN, Zhu P, Gu F, Sun LY, Zhao JX, Liu XY, Guo JL, Bi LQ, Hao YJ, Zhang ZL, Mei YF, Zhang ZY, Liu HX, Li XF, Luo Y, Fang YF, Li ZG, Su Y.
    Int J Rheum Dis; 2016 Jul; 19(7):651-7. PubMed ID: 26268935
    [Abstract] [Full Text] [Related]

  • 10. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
    Alcântara AC, Leite CA, Leite AC, Sidrim JJ, Silva FS, Rocha FA.
    J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
    [Abstract] [Full Text] [Related]

  • 11. The SMILE study -- safety of methotrexate in combination with leflunomide in rheumatoid arthritis.
    Bird P, Griffiths H, Tymms K, Nicholls D, Roberts L, Arnold M, Burnet S, de Jager J, Scott J, Zochling J, Littlejohn G.
    J Rheumatol; 2013 Mar; 40(3):228-35. PubMed ID: 23322457
    [Abstract] [Full Text] [Related]

  • 12. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
    Dougados MR, van der Heijde DM, Brault Y, Koenig AS, Logeart IS.
    J Rheumatol; 2014 Oct; 41(10):1922-34. PubMed ID: 25128520
    [Abstract] [Full Text] [Related]

  • 13. Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.
    Fleischmann R, Koenig AS, Szumski A, Nab HW, Marshall L, Bananis E.
    Rheumatology (Oxford); 2014 Nov; 53(11):1984-93. PubMed ID: 24907147
    [Abstract] [Full Text] [Related]

  • 14. Preliminary evaluation in rheumatoid arthritis activity in patients treated with TNF-alpha blocker plus methotrexate versus methotrexate or leflunomide alone.
    Wisłowska M, Jakubicz D.
    Rheumatol Int; 2007 May; 27(7):641-7. PubMed ID: 17235556
    [Abstract] [Full Text] [Related]

  • 15. Twenty-four-week clinical results of adalimumab therapy in Japanese patients with rheumatoid arthritis: retrospective analysis for the best use of adalimumab in daily practice.
    Kaneko A, Hirano Y, Fujibayashi T, Hattori Y, Terabe K, Kojima T, Ishiguro N.
    Mod Rheumatol; 2013 May; 23(3):466-77. PubMed ID: 22895833
    [Abstract] [Full Text] [Related]

  • 16. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
    Smolen JS, Han C, Bala M, Maini RN, Kalden JR, van der Heijde D, Breedveld FC, Furst DE, Lipsky PE, ATTRACT Study Group.
    Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
    [Abstract] [Full Text] [Related]

  • 17. The effectiveness of leflunomide as a co-therapy of tumour necrosis factor inhibitors in rheumatoid arthritis: a population-based study.
    Finckh A, Dehler S, Gabay C, SCQM doctors.
    Ann Rheum Dis; 2009 Jan; 68(1):33-9. PubMed ID: 18230627
    [Abstract] [Full Text] [Related]

  • 18. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
    Smolen JS, Van Der Heijde DM, St Clair EW, Emery P, Bathon JM, Keystone E, Maini RN, Kalden JR, Schiff M, Baker D, Han C, Han J, Bala M, Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group.
    Arthritis Rheum; 2006 Mar; 54(3):702-10. PubMed ID: 16508926
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
    Jaimes-Hernández J, Meléndez-Mercado CI, Mendoza-Fuentes A, Aranda-Pereira P, Castañeda-Hernández G.
    Reumatol Clin; 2012 Mar; 8(5):243-9. PubMed ID: 22763150
    [Abstract] [Full Text] [Related]

  • 20. Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: a retrospective study.
    Deng D, Zhou J, Li M, Li S, Tian L, Zou J, Wang T, Wu J, Zeng F, Yang J.
    Sci Rep; 2020 Jul 23; 10(1):12339. PubMed ID: 32704073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.